CHOLESTYRAMINE
NDC 42806-267, cholestyramine, powder, for suspension, from EPIC PHARMA, LLC.
- Product NDC
- 42806-267
- Status
- Listed
- Labeler
- EPIC PHARMA, LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42806-267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42806-267-93 | 42806026793 | 378 g in 1 JAR (42806-267-93) |
| 42806-267-97 | 42806026797 | 378 g in 1 CAN (42806-267-97) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c65e556a-3b6a-4466-a7ce-5b24103ed8adNADAC price for package 42806026793
GET /v1/drugs/nadac/42806026793
Use it
Look up 42806-267 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42806-267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42806-267. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.